HERVolution Therapeutics Appoints Professor Jens Juul Holst, Co-discoverer of GLP-1, to Scientific Advisory Board
Co-discoverer of GLP-1 and one of the most highly cited scientists in metabolic research, Holst brings foundational gut-hormone and metabolic-disease expertise to HERVolution's Scientific Advisory Board Holst's guidance will support HERVolution as it advances its lead program, IPT-001 — a...
Read the full story on PR Newswire → Opens the original article on www.prnewswire.comSummary aggregated from PR Newswire's public RSS feed. The full reporting belongs to PR Newswire — please read it on their site.